Stay updated with the latest in AI grants. Here are the top picks for today, curated and summarized by HappyMonkey AI.
DeepCyte Raises $1.5M to Build AI Tools That Detect Drug Toxicity Before Clinical Trials
DeepCyte has received $1.5M for developing AI tools that predict and explain drug toxicity at a single-cell level.
Why it matters: To improve drug safety and efficacy through advanced predictive analytics.
From LLMs to hallucinations, here’s a simple guide to common AI terms
TechCrunch has created an AI glossary to clarify terms like AGI (Artificial General Intelligence) for their coverage of the rapidly evolving artificial intelligence industry.
Why it matters: To understand and communicate effectively about advanced AI technologies and concepts.
At the HumanX conference, everyone was talking about Claude
At the HumanX AI conference, Claude from Anthropic was frequently mentioned as a preferred chatbot over ChatGPT and OpenAI, highlighting its success in enterprise applications.
Why it matters: Understanding market preferences can guide development priorities and feature enhancements for agentic AI tools.
Sam Altman responds to ‘incendiary’ New Yorker article after attack on his home
OpenAI CEO Sam Altman responded to an alleged attack on his home and a critical New Yorker article about his leadership style, acknowledging the impact of narratives around AI safety.
Why it matters: Understanding public perception and narrative impact is crucial for effective communication and crisis management in AI development.